text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2022년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n한미약품(주)\n상장\n2010.07.30\n경영참여\n42,207\n5,000,078\n41.40\n346,035\n100,001\n-\n-\n5,100,079\n41.40\n346,035\n1,399,294\n50,327\n(주)제이브이엠\n상장\n2016.06.09\n경영참여\n129,150\n4,738,544\n39.20\n153,323\n-\n-\n-\n4,738,544\n39.20\n153,323\n206,944\n14,553\n온라인팜(주)\n비상장\n2012.12.15\n경영참여\n3,000\n8,000,000\n100\n13,320\n-\n-\n-\n8,000,000\n100\n13,320\n200,176\n14,533\n(주)에르무루스\n비상장\n1997.02.14\n경영참여\n500\n207,000\n98.60\n-\n-\n-\n-\n207,000\n98.60\n-\n1,978\n286\n일본한미약품(주)\n비상장\n2007.06.08\n경영참여\n38\n500\n100\n8\n-\n-\n-\n500\n100\n8\n1,367\n-705\nHanmi Europe Ltd.\n비상장\n2008.09.18\n경영참여\n7\n3,000\n100\n7\n-\n-\n-\n3,000\n100\n7\n4,583\n-\n한미(중국)유한공사\n비상장\n2016.05.31\n경영참여\n118,333\n-\n100\n11,833\n-\n-\n-\n-\n100\n11,833\n12,071\n-\n북경한미IT유한공사(*1)\n비상장\n2022.11.01\n경영참여\n4,350\n-\n-\n-\n303,920\n4,350\n-\n303,920\n100\n4,350\n4,407\n73,654\nHanmi Healthcare, LLC(*1)\n비상장\n2022.11.01\n경영참여\n1,197\n-\n-\n-\n-\n1,197\n-\n-\n100\n1,197\n1,058\n-10,758\n(주)테라시온바이오메디칼(*1)\n비상장\n2022.11.01\n경영참여\n1,539\n-\n-\n-\n299,824\n1,539\n-\n299,824\n24.67\n1,539\n7,692\n-26\n(주)에비드넷(*1)\n비상장\n2022.11.01\n경영참여\n3,856\n-\n-\n-\n270,390\n3,856\n-\n270,390\n29.89\n3,856\n14,866\n-1,360\nSpectrum Pharmaceuticals, Inc.\n상장\n2022.03.02\n단순투자\n3,737\n-\n-\n-\n2,482,389\n3,737\n-2,573\n2,482,389\n1.22\n1,164\n130,960\n-97,383\nAlpha Tau Medical(*1)\n상장\n2022.11.01\n단순투자\n5,961\n-\n-\n-\n1,000,000\n5,961\n-1,931\n1,000,000\n1.45\n4,030\n50,052\n-31,243\n연합뉴스TV\n비상장\n2011.06.01\n단순투자\n500\n100,000\n0.83\n176\n-\n-\n-\n100,000\n0.83\n176\n69,221\n9,307\n토모큐브\n비상장\n2016.03.30\n단순투자\n1,000\n314,300\n6.02\n55\n-\n-\n-\n314,300\n6.02\n55\n29,962\n-19,349\n바이오앱\n비상장\n2020.08.10\n단순투자\n4,500\n500,000\n5.16\n4,820\n-\n-\n-273\n500,000\n4.87\n4,547\n14,718\n-22,901\nNOOM, INC.(*1)\n비상장\n2022.11.01\n단순투자\n210\n-\n0.09\n-\n61,478\n210\n-\n61,478\n0.09\n210\n8,402\n-486\nINNOVACIVE, Inc.(Amplify Surgical, Inc)(*1)\n비상장\n2022.11.01\n단순투자\n2,266\n-\n4.43\n-\n653,702\n2,266\n-\n653,702\n4.43\n2,266\n-\n-\nIntuitiveX, Inc.(*1)\n비상장\n2022.11.01\n단순투자\n283\n-\n6.23\n-\n2,000,000\n283\n-\n2,000,000\n4.97\n283\n-\n-\nAltPep Corporation(*1)\n비상장\n2022.11.01\n단순투자\n605\n-\n1.17\n-\n377,557\n605\n-\n377,557\n1.17\n605\n-\n-\nBloom Life(Bloom Technologies, INC)(*1)\n비상장\n2022.11.01\n단순투자\n1,425\n-\n-\n-\n1,153,262\n1,425\n-\n1,153,262\n5.00\n1,425\n-\n-\n매쉬업엔젤스 가치성장벤처투자조합(*1)\n비상장\n2022.11.01\n단순투자\n1,000\n-\n-\n-\n1,000\n1,000\n-\n1,000\n-\n1,000\n-\n-\n조인앤조인(*1)\n비상장\n2022.11.01\n단순투자\n502\n-\n-\n-\n51,800\n502\n-\n51,800\n2.87\n502\n8\n-2\n합 계\n-\n-\n529,577\n-\n26,931\n-4,777\n-\n-\n551,731\n-\n-\n* 시장성 있는 지분증권의 공정가액은 보고기간 종료일 현재의 종가(당기말 현재의 종가가 없는 경우에는 직전 거래일의 종가)로 측정하였으며, 시장성없는 지분증권의 공정가액은 신뢰성있게 측정할 수 없어 피투자회사의 입수 가능한 최근 재무제표상의 순자산가액에 대한 당사 지분액으로 산정하였습니다.\n(*1) 당기 중 한미헬스케어(주)를 흡수합병 함에 따라 취득하였습니다.\n']"
